close
Trend Chart on Innovative Bioindustries – September 12th
News

Trend Chart on Innovative Bioindustries – September 12th

Trend Chart on Innovative Bioindustries – September 12th

FEATURE STORY
The landscape of early clinical gene therapies outside oncology

BASIC SCIENCE
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL

CLINICAL TRIALS/DATA
ATL1102 for DMD commencement of European regulatory interactions
UniQure stays a step ahead in hemophilia B

FINANCIAL DATA
Passage Bio Closes $110 Million Series B Financing
Achilles Therapeutics raises 100 M£ in oversubscribed series B financing
Nkarta Therapeutics raises $114 Million in Series B financing to advance multiple programs into clinical trial

M&A – AGREEMENTS
Phio Pharmaceuticals announces research collaboration with Carisma Therapeutics to evaluate its self-delivering RNAi technology
Vertex to acquire Semma Therapeutics with a goal of developing curative cell-based treatments for type 1 diabetes
Sumitomo Dainippon buys five Roivant companies for $3 Billion with option to buy six more

Click here to read these articles: Trend Chart on Innovative Bioindustries


COMMENTS ARE OFF THIS POST